Nicola E Wilsher (Nicola Wilsher)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Molecules (Basel, Switzerland)

Xenobiotica; the fate of foreign compounds in biological systems

This page only lists publications with an associated author ORCID identifier.

Publications

Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Ketan C Ruparelia, Keti Zeka, Kenneth J M Beresford, Nicola E Wilsher, Gerry A Potter, Vasilis P Androutsopoulos, Federico Brucoli, Randolph R J Arroo
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules (Basel, Switzerland) 29 (2) (2024)
Vanessa Martins, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton, Nicola E Wilsher
A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica; the fate of foreign compounds in biological systems 52 (8) (2022)
Vanessa Martins, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton, Nicola E Wilsher
A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica; the fate of foreign compounds in biological systems 52 (8) (2022)